Abstract:Cardiovascular disease (CVD) due to atherosclerosis is the main cause of death in both the elderly and patients with metabolic diseases, including diabetes. Aging processes contribute to the pathogenesis of atherosclerosis. Calorie restriction (CR) is recognized as a dietary intervention for promoting longevity and delaying age-related diseases, including atherosclerosis. Sirt1, an NAD<sup>+</sup>-dependent deacetylase, is considered an anti-aging molecule and is induced during CR. Sirt1 deacetylates target proteins and is linked to cellular metabolism, the redox state and survival pathways. Sirt1 expression/activation is decreased in vascular tissue undergoing senescence. Sirt1 deficiency in endothelial cells (ECs), vascular smooth muscle cells (VSMCs) and monocytes/macrophages contributes to increased oxidative stress, inflammation, foam cell formation, senescences impaired nitric oxide production and autophagy, thereby promoting vascular aging and atherosclerosis. Endothelial dysfunction, activation of monocytes/macrophages, and the functional and phenotypical plasticity of VSMCs are critically implicated in the pathogenesis of atherosclerosis through multiple mechanisms. Therefore, the activation of Sirt1 in vascular tissue, which includes ECs, monocytes/macrophages and VSMCs, may be a new therapeutic strategy against atherosclerosis and the increasing resistance to the metabolic disorder-related causal factors of CVD. In this review, we discuss the protective role of Sirt1 in the pathophysiology of vascular aging and atherosclerosis.

The Role of Sirtuin1 in Regulating Endothelial Function, Arterial Remodeling and Vascular Aging

Sirtuins family as a target in endothelial cell dysfunction: implications for vascular ageing

The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update

From Microcirculation to Aging-Related Diseases: A Focus on Endothelial SIRT1

[Deacetylase SIRT1 and Vascular Endothelial Function].

Sirt1 Inhibits Oxidative Stress in Vascular Endothelial Cells

The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis

SIRT-Associated Attenuation of Cellular Senescence in Vascular Wall

Histone Deacetylase Sirt1, Smooth Muscle Cell Function, And Vascular Diseases

SIRT1 in metabolic syndrome: where to target matters.

SIRT1 in vascular related diseases:its progress

Roles of SIRT3 in Heart Failure: from Bench to Bedside.

The Role of Sirtuin-1 in the Vasculature: Focus on Aortic Aneurysm

Sirtuin 1: A Target for Kidney Diseases

Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease

SIRT1‐mediated ERβ Suppression in the Endothelium Contributes to Vascular Aging

Regulation of SIRT1 in aging: Roles in mitochondrial function and biogenesis

The role of sirtuin 1 in ageing and neurodegenerative disease: A molecular perspective

Novel Role of the SIRT1 in Endocrine and Metabolic Diseases

Research progress of sirtuins in renal and cardiovascular diseases.

The role of SIRT1 in kidney diseases